BiotechTube

Diclofenac Sodium Topical Gel, 1% + Voltaren Topical Gel, 1% + Vehicle Diclofenac Sodium Topical Gel

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Osteoarthritis

Conditions

Osteoarthritis

Trial Timeline

Apr 1, 2014 → Dec 1, 2014

NCT ID
NCT02121002

About Diclofenac Sodium Topical Gel, 1% + Voltaren Topical Gel, 1% + Vehicle Diclofenac Sodium Topical Gel

Diclofenac Sodium Topical Gel, 1% + Voltaren Topical Gel, 1% + Vehicle Diclofenac Sodium Topical Gel is a phase 3 stage product being developed by Amneal Pharmaceuticals for Osteoarthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT02121002. Target conditions include Osteoarthritis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02121002Phase 3Completed

Competing Products

20 competing products in Osteoarthritis

See all competitors
ProductCompanyStageHype Score
Duloxetine + PlaceboEli LillyPhase 3
77
LY2828360 + PlaceboEli LillyPhase 2
52
Investigational Medical Product (IMP) administered in parent studyEli LillyPhase 3
77
Duloxetine + Sugar pillEli LillyApproved
85
UBX0101 or placeboUnity BiotechnologyPre-clinical
15
UBX0101Unity BiotechnologyPhase 1
25
UBX0101Unity BiotechnologyPhase 2
44
UBX0101Unity BiotechnologyPhase 1
25
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
52
Sodium hyaluronate + placebo injectionDaiichi SankyoPhase 3
77
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
52
Capsaicin Topical SolutionAstellas PharmaApproved
85
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
52
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
52
Duloxetine + PlaceboShionogiPhase 3
77
DuloxetineShionogiPhase 3
77
ONO-4474 Part A1 + Placebo Part A1 + ONO-4474 Part A2 + Placebo Part A2 + ONO-4474 Part B + Placebo Part B + ONO-4474 Part C + Placebo Part C + ONO-4474 Part D + Placebo Part DOno PharmaceuticalPhase 1
33
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
52
Duloxetine + PlaceboEli LillyPhase 3
77
LY3556050 + PlaceboEli LillyPhase 2
52

Other Products from Amneal Pharmaceuticals

CREXONT ERApproved
80
CREXONT ERApproved
80
Testosterone Topical Gel, 1.62% Metered Pump + AndroGel (testosterone gel) 1.62% Metered-Dose PumpPhase 3
72
Phenazopyridine Hydrochloride + PlaceboPhase 3
72
Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg + Phenazopyridine Hydrochloride Tables, USP 200 mgPhase 3
72